Targeted next-generation sequencing and parental genotyping in sporadic Chinese Han deaf patients

被引:14
|
作者
He, L. [1 ,2 ,3 ,4 ]
Pang, X. [5 ]
Liu, H. [6 ]
Chai, Y. [1 ,2 ,3 ]
Wu, H. [1 ,2 ,3 ]
Yang, T. [1 ,2 ,3 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Ear Inst, Sch Med, Shanghai, Peoples R China
[3] Shanghai Key Lab Translat Med Ear & Nose Dis, Shanghai, Peoples R China
[4] Chengdu Integrated TCM & Western Med Hosp, Dept Otorhinolaryngol Head & Neck Surg, Chengdu, Sichuan, Peoples R China
[5] Nantong Univ, Dept Otorhinolaryngol Head & Neck Surg, Affiliated Hosp 5, Taizhou Peoples Hosp, Nanjing, Jiangsu, Peoples R China
[6] Gannan Med Univ, Dept Pediat Surg, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
deafness; parental genotyping; pathogenic variant; sporadic; targeted next-generation sequencing;
D O I
10.1111/cge.13182
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The interpretation of the targeted next-generation sequencing (NGS) results can be challenging for variants identified in the sporadic deaf patients. In this study, we performed targeted NGS of 143 deafness-associated genes in 44 sporadic deaf patients and use parental genotyping to test whether the candidate pathogenic variants complied with recessive or de novo pattern. Of 29 recessive candidate variants with minor allele frequencies (MAFs) less than 0.005, 3 pairs of apparent compound heterozygous variants were inherited from the same parental allele, ruling out their pathogenic roles. In addition, non-segregation of an OTOA p.Gln293Arg variant led to the discovery of a genomic microdeletion of OTOA on the opposite allele by copy number variation analysis. Overall, 13 pairs of recessive candidate variants were deemed causative in 13 patients. Of the 28 dominant candidate variants with MAFs less than 0.0005, none occurred de novo, suggesting that they were not disease causing. Our results revealed that targeted NGS in sporadic deaf patients may generate a significant false-positive rate. Parental genotyping is a simple but effective step toward minimizing the false-positive results. Our study also showed that de novo variants in dominant deafness genes may not be a common cause for sporadic deafness.
引用
收藏
页码:899 / 904
页数:6
相关论文
共 50 条
  • [31] Genotyping 1000 yeast strains by next-generation sequencing
    Stefan Wilkening
    Manu M Tekkedil
    Gen Lin
    Emilie S Fritsch
    Wu Wei
    Julien Gagneur
    David W Lazinski
    Andrew Camilli
    Lars M Steinmetz
    BMC Genomics, 14
  • [32] Genotyping 1000 yeast strains by next-generation sequencing
    Wilkening, Stefan
    Tekkedil, Manu M.
    Lin, Gen
    Fritsch, Emilie S.
    Wei, Wu
    Gagneur, Julien
    Lazinski, David W.
    Camilli, Andrew
    Steinmetz, Lars M.
    BMC GENOMICS, 2013, 14
  • [33] NEXT-GENERATION SEQUENCING (NGS) FOR BLOOD GROUP GENOTYPING
    Fichou, Y.
    Audrezet, M. P.
    Gueguen, P.
    Dupont, I
    Jamet, D.
    Le Marechal, C.
    Ferec, C.
    VOX SANGUINIS, 2013, 105 : 59 - 59
  • [34] IMPLEMENTATION OF NEXT-GENERATION SEQUENCING (NGS) FOR HLA GENOTYPING
    Christiansen, Mette
    Bonde, Lisbeth
    Walther, Tina
    Moller, Bjarne Kuno
    TISSUE ANTIGENS, 2015, 85 (05): : 373 - 373
  • [35] HLA genotyping by next-generation sequencing of complementary DNA
    Segawa, Hidenobu
    Kukita, Yoji
    Kato, Kikuya
    BMC GENOMICS, 2017, 18
  • [36] HLA genotyping by next-generation sequencing of complementary DNA
    Hidenobu Segawa
    Yoji Kukita
    Kikuya Kato
    BMC Genomics, 18
  • [37] Identification of HLA-A*31:150 by next-generation sequencing in a Chinese Han individual
    Liang, Si-Zhe
    Quan, Zhan-Rou
    Hong, Wen-Xu
    Zou, Hong-Yan
    HLA, 2019, 94 (04) : 373 - +
  • [38] Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies
    Harding, James J.
    Nandakumar, Subhiksha
    Armenia, Joshua
    Khalil, Danny N.
    Albano, Melanie
    Ly, Michele
    Shia, Jinru
    Hechtman, Jaclyn F.
    Kundra, Ritika
    El Dika, Imane
    Do, Richard K.
    Sun, Yichao
    Kingham, T. Peter
    D'Angelica, Michael I.
    Berger, Michael F.
    Hyman, David M.
    Jarnagin, William
    Klimstra, David S.
    Janjigian, Yelena Y.
    Solit, David B.
    Schultz, Nikolaus
    Abou-Alfa, Ghassan K.
    CLINICAL CANCER RESEARCH, 2019, 25 (07) : 2116 - 2126
  • [39] Application of metagenomic next-generation sequencing and targeted metagenomic next-generation sequencing in diagnosing pulmonary infections in immunocompetent and immunocompromised patients
    Liu, Yong
    Wu, Wencai
    Xiao, Yunping
    Zou, Hongyan
    Hao, Sijia
    Jiang, Yanfang
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [40] Targeted Next-Generation Sequencing for Diagnostics and Forensics
    Minogue, Timothy D.
    Koehler, Jeffrey W.
    Norwood, David A.
    CLINICAL CHEMISTRY, 2017, 63 (02) : 450 - 452